Kampala, Uganda | XINHUA | A phase 2 trial of a COVID-19 vaccine candidate conducted in China has found that the vaccine is safe and induces an immune response, according to a new study published Monday in medical journal The Lancet. The results provide data from a wider group of participants …
Read More »